{"id":27903,"date":"2026-06-22T11:41:16","date_gmt":"2026-06-22T15:41:16","guid":{"rendered":"https:\/\/www.cryoport.com\/?p=27903"},"modified":"2026-06-22T11:52:14","modified_gmt":"2026-06-22T15:52:14","slug":"un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/","title":{"rendered":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes. <\/p>\n","protected":false},"author":38,"featured_media":27909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[154],"tags":[478,592,516],"class_list":["post-27903","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articulos","tag-gestion-de-la-cadena-de-suministro","tag-terapia-celular","tag-terapia-genica"],"acf":[],"yoast_head":"\nMark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-22T15:41:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-22T15:52:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica\",\"datePublished\":\"2026-06-22T15:41:16+00:00\",\"dateModified\":\"2026-06-22T15:52:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/\"},\"wordCount\":25,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Base-to-Base-Podcast.png\",\"keywords\":[\"Gesti\u00f3n de la Cadena de Suministro\",\"Terapia celular\",\"Terapia g\u00e9nica\"],\"articleSection\":[\"Art\u00edculos\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/\",\"name\":\"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Base-to-Base-Podcast.png\",\"datePublished\":\"2026-06-22T15:41:16+00:00\",\"dateModified\":\"2026-06-22T15:52:14+00:00\",\"description\":\"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Base-to-Base-Podcast.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Base-to-Base-Podcast.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/pagina-de-inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/es\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems","description":"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/","og_locale":"es_ES","og_type":"article","og_title":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems","og_description":"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.","og_url":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/","og_site_name":"Cryoport Systems","article_published_time":"2026-06-22T15:41:16+00:00","article_modified_time":"2026-06-22T15:52:14+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"Escrito por":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/es\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica","datePublished":"2026-06-22T15:41:16+00:00","dateModified":"2026-06-22T15:52:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/"},"wordCount":25,"publisher":{"@id":"https:\/\/www.cryoport.com\/es\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png","keywords":["Gesti\u00f3n de la Cadena de Suministro","Terapia celular","Terapia g\u00e9nica"],"articleSection":["Art\u00edculos"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/","url":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/","name":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png","datePublished":"2026-06-22T15:41:16+00:00","dateModified":"2026-06-22T15:52:14+00:00","description":"Mark Sawicki, presidente y director ejecutivo de Cryoport Systems, se uni\u00f3 hace poco al presentador Jim Cornall en el podcast \u00abBase to Base Biotech\u00bb para mantener una conversaci\u00f3n en la que se trataron diversos temas sobre el panorama cambiante de la terapia celular y g\u00e9nica, y el papel que desempe\u00f1a la infraestructura especializada de la cadena de suministro a la hora de facilitar el acceso de los pacientes.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2026\/06\/Base-to-Base-Podcast.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/es\/un-nuevo-articulo-de-liderazgo-intelectual-de-isct-analiza-por-que-el-crecimiento-de-la-cgt-exige-un-modelo-operativo-diferente\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/es\/pagina-de-inicio\/"},{"@type":"ListItem","position":2,"name":"Mark Sawicki se une a Base to Base Biotech para hablar sobre el futuro de la log\u00edstica de la terapia celular y g\u00e9nica"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/es\/#website","url":"https:\/\/www.cryoport.com\/es\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/es\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cryoport.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/es\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/posts\/27903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/comments?post=27903"}],"version-history":[{"count":2,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/posts\/27903\/revisions"}],"predecessor-version":[{"id":27923,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/posts\/27903\/revisions\/27923"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/media\/27909"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/media?parent=27903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/categories?post=27903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/es\/wp-json\/wp\/v2\/tags?post=27903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}